Tuberculosis is a global epidemic that annually accounts for more than 3 million deaths worldwide. Because of the capacity of M. tuberculosis to establish a latent infection, an estimated 2 billion people worldwide are infected with M. tuberculosis. Immunodeficiency caused by malnutrition, old age or HIV infection enhances development of active disease, either from a primary infection or more likely from reactivation of a latent infection. However, the environmental cues responsible for initiating latent infection in the host are not clearly understood. We previously showed that the gas carbon monoxide (CO) produced by host macrophages triggers a dormancy response in mycobacteria mediated by a bacterial two-component system. We also showed that carbon monoxide is well tolerated by mycobacteria, suggesting that mycobacteria can resist CO toxicity, and further have recently discovered a novel gene in M. tuberculosis that affords such resistance. We are currently characterizing the role of this gene in CO resistance, including its precise biochemical mechanism, interacting partners, metabolic effects and role in pathogenesis. Furthermore, we are identifying additional CO resistance genes and characterizing their functions and role in pathogenesis.

In addition to studying the role of carbon monoxide in M. tuberculosis pathogenesis, we are broadly interested in the metabolic and physiologic adaptations of M. tuberculosis during latency. Because successful M. tuberculosis infection occurs as a consequence of complex interactions with the host, we also are studying unique cellular and immunologic responses of the host that facilitate M. tuberculosis survival. Our hope is to identify novel microbial and host factors that can be inhibited or modulated to improve the treatment or prevention of tuberculosis.


Medical School
Cornell University Medical College (2001)
University of California, San Francisco (2003), Internal Medicine
University of California at San Francisco (2007), Infectious Disease

Research Interest

  • Innate immune response to intracellular pathogens
  • Microbial pathogenesis
  • Mucosal immunology
  • Mycobacterium tuberculosis
  • Role of carbon monoxide (CO) in host-pathogen interactions


Featured Publications LegendFeatured Publications

EBV-driven HIV-associated diffuse large B-cell lymphoma causing profound lactic acidosis.
Prokesch BC, Shiloh MU Blood 2014 Aug 124 6 842
Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages.
Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS Cell Host Microbe 2012 May 11 5 469-80
Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence.
Ohol YM, Goetz DH, Chan K, Shiloh MU, Craik CS, Cox JS Cell Host Microbe 2010 Mar 7 3 210-20
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?
Shiloh MU, DiGiuseppe Champion PA Curr. Opin. Microbiol. 2010 Feb 13 1 86-92

Honors & Awards

  • The Department of Internal Medicine Chair’s Pilot Awards
    A Synthetic Lethal Genetic Interaction Map in Mycobacterium tuberculosis (2015-2017)
  • UTSW High Impact/High Risk Award
    Research award for development of a novel M. tuberculosis vaccine (2012)
  • Disease Oriented Clinical Scholar, UTSW
  • NIH/NIAID K08 award
    2008-2012 (2008)
  • Sandler Family Foundation Discovery Award
    Research award for highly innovative research (2006)
  • Giannini Family Foundation Research Fellowship, 2005-2008
    Honors research fellows in the state of California (2005)

Professional Associations/Affiliations

  • American Association of Immunologists (2014)
  • American Society of Microbiology (2013)
  • Infectious Disease Society of America (2010)